Indaptus Therapeutics, Inc. (INDP) Dividend History

Indaptus Therapeutics, Inc. is a biotechnology company focused on developing innovative immuno-oncology and infectious disease therapies. The company leverages its proprietary INDP-001 platform to create targeted treatments aimed at stimulating the immune system to fight cancer and infectious diseases. Headquartered in the United States, Indaptus aims to advance therapies that address unmet medical needs through cutting-edge research and development.

3 Columbus Circle, New York, NY, 10019
Phone: (646) 427-2727
Website: https://www.indaptusrx.com

Dividend History

Indaptus Therapeutics, Inc. currently does not pay dividends

Company News

  • Indaptus Therapeutics, a clinical-stage biotechnology company, highlights its accomplishments in 2024 and outlines its strategic goals for 2025, including the launch of a combination trial with BeiGene's tislelizumab and the expansion of its Decoy20 clinical trial.

    GlobeNewswire Inc.
  • Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. Butterfly Network posted GAAP loss of 21 cents per share versus market estimates for a loss of 14 cents per share. The company’s quarterly sales came in at sales came in $16.52 million versus estimates of $15.35 million. Butterfly Network shares dipped 21.7% to $1.1588 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Enveric Biosciences, Inc. (NASDAQ: ENVB) gained 177.1% to $2.30 after the company announced it has signed three non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of compounds. Societal CDMO, Inc. (NASDAQ: SCTL) shares climbed 132.7% to $1.07 as the company agreed to be acquired by CoreRx, Inc. Volcon, Inc. (NASDAQ: VLCN) gained 55.4% to $1.8802 after surging around 39% on Wednesday. Sidus Space, Inc. (NASDAQ: SIDU) climbed 39.7% to $7.78. Ocean Biomedical, Inc. (NASDAQ: OCEA) gained 36.4% to $2.1008. Ocean Biomedical announced joint venture partner, Virion Therapeutics to present clinical study data at 2024 APASL Global Liver Meeting. Inseego Corp. (NASDAQ: INSG) rose 34.5% to $3.00. Vertex, Inc. (NASDAQ: VERX) jumped 29.8% to $32.97 after the company reported better-than-expected fourth-quarter results and issued strong FY24 guidance. iHeartMedia, Inc. (NASDAQ: IHRT) rose 29.1% to $2.93 following fourth-quarter results. Agrify Corporation (NASDAQ: AGFY) gained 27% to $0.6161. Agrify announced a $3.4 million sales order from New Jersey woman-owned business HarvestWorks Farm. Renalytix Plc (NASDAQ: RNLX) climbed 26.5% to $1.05 after the company announced that effective Mar. 1, the US approved adding the company's kidneyintelX.dkd to its 10-year Governmentwide Acquisition Contract. Tutor Perini Corporation (NYSE: TPC) gained 26% to $11.64 following fourth-quarter results. Bright Scholar Education Holdings Limited (NYSE: BEDU) gained 25.3% to $2.3178. C3.ai, Inc. (NYSE: AI) shares rose 24.6% to $37.00 after the company reported better-than-expected third-quarter financial results. Sterling Check Corp. (NASDAQ: STER) jumped 24.6% to $15.49 after the company agreed to be acquired by First Advantage for approximately $2.2 billion, including outstanding debt. Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) gained 24% to $2.00. Adial Pharmaceuticals was awarded a new patent covering AD04 for the potential treatment of opioid use disorder. Revance Therapeutics, Inc. (NASDAQ: RVNC) jumped 24% to $7.02 after the company reported better-than-expected quarterly financial results. Latham Group, Inc. (NASDAQ: SWIM) climbed 22.8% to $3.36. Avidity Biosciences, Inc. (NASDAQ: RNA) jumped 22.5% to $18.70. Avidity Biosciences announced an oversubscribed $400 million private placement. Pure Storage, Inc. (NYSE: PSTG) rose 21.9% to $51.35 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter revenue guidance above estimates. ...

    Benzinga
  • Indaptus (INDP) announces positive pre-clinical efficacy data from a poster presentation made at a scientific conference from its proprietary Decoy platform pre-clinical study. Stock is up 22%.

    Zacks Investment Research
  • Here are three penny stocks for your watchlist right now The post Hot Penny Stocks to Watch Right Now? 3 For Your List in May appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: MULN
Page data last updated 07/23/2025 18:03:59 UTC